Secondary mutations in viruses resistant to HIV-1 integrase inhibitors that restore viral infectivity and replication kinetics-Reference-Cited by-同舟云学术

Secondary mutations in viruses resistant to HIV-1 integrase inhibitors that restore viral infectivity and replication kinetics

Published:2009-02 Issue:2 Volume:81 Page:141-146
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Nakahara Koichiro,Wakasa-Morimoto Chiaki,Kobayashi Masanori,Miki Shigeru,Noshi Takeshi,Seki Takahiro,Kanamori-Koyama Mikiko,Kawauchi Shinobu,Suyama Akemi,Fujishita Toshio,Yoshinaga Tomokazu,Garvey Edward P.,Johns Brian A.,Foster Scott A.,Underwood Mark R.,Sato Akihiko,Fujiwara Tamio

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference23 articles.

1. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone;Adachi;J. Virol.,1986

2. Analysis of human immunodeficiency virus type 1 integrase mutants;Ansari-Lari;Virology,1995

3. S-1360 Shionogi-GlaxoSmithKline;Billich;Curr. Opin. Investig. Drugs,2003

4. Analysis of early human immunodeficiency virus type 1 DNA synthesis by use of a new sensitive assay for quantifying integrated provirus;Brussel;J. Virol.,2003

5. A quantitative assay for HIV DNA integration in vivo;Butler;Nat. Med.,2001

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Simulation in Drug Design: An Overview of Molecular Dynamics Methods;Applied Computer-Aided Drug Design: Models and Methods;2023-12-07

2. Evaluation of CCR5-Δ32 mutation and HIV-1 surveillance drug-resistance mutations in peripheral blood mononuclear cells of long-term non progressors of HIV-1-infected individuals;Future Virology;2022-07

3. Coevolved Multidrug-Resistant HIV-1 Protease and Reverse Transcriptase Influences Integrase Drug Susceptibility and Replication Fitness;Pathogens;2021-08-24

4. Consensus Integrase of a New HIV-1 Genetic Variant CRF63_02A1;Acta Naturae;2019-03-15

5. Barrier to Resistance of Dolutegravir in Two-Drug Combinations;Antimicrobial Agents and Chemotherapy;2019-03